Navigation Links
DuPont Chief Financial Officer Reviews Company's Accelerated Growth Plan
Date:3/20/2008

NEW YORK, March 20 /PRNewswire-FirstCall/ -- At a conference with security analysts today, DuPont (NYSE: DD) Executive Vice President & Chief Financial Officer Jeffrey L. Keefer reviewed the company's accelerated growth plan, designed to nearly double DuPont's earnings growth rate over the next three years.

"As a market-driven science company, DuPont's competitive advantage is new product innovation," Keefer said. "Our rising return from innovation and rapid growth in emerging markets are key growth drivers for us. We will continue to execute our growth strategies while maintaining financial discipline and increasing productivity gains across the company."

The actions DuPont is taking are expected to increase the company's revenue growth rate from 5 percent to about 7-9 percent per year, including 1- 2 percent from bolt-on acquisitions, Keefer said.

Based on current plans, DuPont projects it can achieve earnings per share growth of 10 percent or more, on average, between 2008 and 2010, despite anticipated declines in pharmaceutical royalties after patents expire in 2010. Keefer said the company's goal is to achieve 2010 earnings per share within a range of $4.05 to $4.30. In 2007, the company earned $3.28 per share, excluding net significant item charges of $.06 per share.

The company intends to capitalize on rising global demand for its science- based products in agriculture and safety and protection; further penetrate key markets in the world's rapidly growing geographies; and extend its productivity improvement programs. DuPont expects to generate $1.7 billion in productivity gains over the next three years by continuing efforts already under way to streamline and simplify its supply chains and business support operations.

DuPont is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont's filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Alexander M. Cutler Nominated for Election to DuPont Board of Directors
2. Woman Sues DuPont and Asbestos Manufacturers After Developing Mesothelioma From Exposure to Asbestos in Husbands Work Clothes
3. DuPont Strengthens Leading Biotechnology Position with Leadership Changes
4. DuPont Responds to Spelter, W.Va. Lawsuit Rulings
5. DuPont Pledges $1 Million to World Food Prize
6. DuPont Hosts Meeting of Leading Plant Scientists to Improve World Agricultural Productivity
7. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
8. DuPont Announces Leadership Changes
9. DuPont Opens Fluoropolymer Production Plant in China
10. DuPont Licenses Breakthrough Automotive Coating Technology to German Paint Maker
11. New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
Breaking Medicine Technology: